In 2022, the Global AI-powered Computed Tomography Diagnostic Imaging Market was valued at $1.51 billion, and is projected to reach a market size of $9.23 billion by 2030. Over the forecast period of 2023-2030, market is projected to grow at a CAGR of 25.4%.
Market Overview:
Artificial intelligence has completely revolutionized the medical diagnostic imaging landscape as it offers medical experts improved diagnostic accuracy and efficient treatment planning. The technology has created a new path for disease diagnosis and evaluation of medical images. The integration of AI and IoT has also advanced clinical trial outcomes and next-generation diagnostic methods. The emergence of new AI software and the incorporation of these tools for routine diagnosis will allow for more accuracy and precision. It can aid physicians in the execution of the image-capturing procedure and provide support to diagnose these images for the individualized treatment of every patient. Researchers have integrated AI to automatically identify complicated patterns and provide quantitative evaluations. Moreover, AI is an integral boosting power of processing a large number of medical images and therefore, unveils disease symptoms that may be difficult to be recognized normally. Thus, AI-powered Computed Tomography Diagnostic Imaging market is anticipated to grow during the forecast timeline.
COVID-19 Impact on the global AI-powered Computed Tomography Diagnostic Imaging Market:
The outbreak of the coronavirus has broadly spread all over the world since the latter phase of 2019. Artificial intelligence with the use of deep learning technology has witnessed great success in the medical imaging sector due to its high ability of feature extraction through large data sets. It was applied mainly to identify and differentiate bacterial and viral pneumonia. Attempts have also been made to recognize and diagnose various imaging features of chest CT, resulting in the rise in the popularity of AI-powered Computed Tomography Diagnostic Imaging market amid the pandemic. However, the rising COVID-19 cases across the world and emerging AI technologies it has boosted the demand for AI imaging and telehealth by providing remote access to images and reports. It also highlights the importance of expanding the use of AI and machine learning in imaging security, with the goal of improving.
Market Drivers:
The increasing inclination of doctors and medical experts towards AI is boosting the market growth:
The growing recognition of the advantages offered by AI technologies and their widescale utilization areas has led to the increased adoption of AI in the healthcare and medical sectors as well. Several key operators in the medical imaging market are beginning to collaborate with leading AI technology providers to innovate AI-based solutions for applications in healthcare. Such approaches offer lucrative and advanced solutions to their consumers and establish their dominance in this dynamic market space. The escalating demand for AI-based techniques and advancements is encouraging companies to gain momentum from it in terms of developing more advanced products and technologies. This in return is likely to generate new opportunities for the players in the AI-powered CT diagnostic imaging market.
The surging investments in the healthcare sector are likely to boost the global AI-powered Computed Tomography diagnostic imaging market:
The increasing awareness about the benefits offered by AI technologies, and their widespread applications in the healthcare sector has led to a steep rise in the adoption of AI technologies for medical purposes, thus augmenting the AI-powered Computed Tomography diagnostic imaging market. Several healthcare facilities and hospitals have adopted artificial intelligence as a more desirable and efficient solution for clinical use. Major leading companies in AI in the medical imaging market are hugely investing in AI technologies to make more use of it. Companies and researchers are coming together to create effective AI-based platforms.
Market Restraints:
Lack of awareness in underdeveloped and developing countries is slowing down the market growth:
The market size is restrained in developing nations as well as in some underdeveloped countries as health awareness remains lower. Many people in developing countries are known to neglect their regular health check-ups and have really low knowledge levels about mild pains and the complications associated with them. Also, advanced technologies like AI and ML require experts and a highly skilled workforce to function, and a lack of employees with relevant knowledge domain makes it difficult for all the players to have any profit in the developing regions narrowing down the scope and hindering the growth of the AI-powered computed tomography diagnostic imaging devices market.
AI-POWERED COMPUTED TOMOGRAPHY DIAGNOSTIC MARKET REPORT COVERAGE:
REPORT METRIC |
DETAILS |
Market Size Available |
2022 - 2030 |
Base Year |
2022 |
Forecast Period |
2023 - 2030 |
CAGR |
25.4% |
Segments Covered |
By Type, Solution, Technology, Application, End User, Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
Key Companies Profiled |
Agfa Healthcare, Ada Health GmbH, Arterys, Bay Labs, Inc.(Caption Health Inc.), Babylon, BenevolentAI, Butterfly Network, Inc., EchoNous, Inc., Enlitic, Inc., Gauss Surgical, GE Healthcare, IBM Corporation, Lunit Inc., Microsoft Corporation, NVIDIA Corporation, Philips Healthcare, OrCam, Qure.ai, Siemens Healthineers AG, Zebra Medical Vision |
This research report on the global AI-powered Computed Tomography Diagnostic Imaging Market has been segmented and sub-segmented based on Type, Solution, Technology, Application, End User, Regions, and Key Companies.
Based on the type, the AI-powered computed tomography diagnostic imaging market has been segmented into 3 segments – Low Slice, Medium Slice, and High Slice.
The high slice, more than 64 slices segment dominates the market accounting for the majority of the revenue share of over 34.8% in 2023. The growing demand for accurate diagnostic imaging solutions is the major factor predicted to drive the segment. It also emits 80% less radiation as compared to mid-end slice technology which has 64 slices. These devices also provide detailed images of obese patients.
Based on the solution, the AI-powered computed tomography diagnostic imaging market has been segmented into 2 segments – Software Tools/Platforms and Services. The Services segment is further sub-segments into 2 parts – Integration and Deployment.
Deep Learning
Computer Vision
Others
Based on the technology, the AI-powered computed tomography diagnostic imaging market has been segmented into 3 segments – Deep Learning, Computer Vision, and Others.
Oncology
Neurology
Cardiovascular
Musculoskeletal
Others
Based on the application, the AI-powered computed tomography diagnostic imaging market has been segmented into 5 segments – Oncology, Neurology, Cardiovascular, Musculoskeletal, and Others.
Based on the end user, the AI-powered Computed Tomography Diagnostic Imaging Market has been segmented into 5 segments – Hospitals, Clinics, Diagnostic Centres, R&D Centres, and Others. The Clinics segment holds the dominance and has the largest revenue share of around 19% of the AI-powered CT diagnostic imaging market in 2023. Clinics are escalating the use of advanced technologies like AI algorithms, machine learning algorithms, and IoT to streamline workflow in these medical setups. AI-powered image analytics can assist clinics to reduce scan time which could lead to less complexity and healthcare providers to operate with improved operational efficiency and cost cuttings.
North America
Europe
Asia-Pacific
South America
Middle-East and Africa
Based on region, the AI-powered Computed Tomography Diagnostic Imaging Market has been segmented into 5 major regions – North America, Europe, Asia-Pacific, South America, Middle-East, and Africa. North America holds the largest market share of over 38.12% in 2023 and is predicted to continue its dominance in the coming years as well. The occupancy of a large number of market key players in the region and the growing number and incidence rate of the diseases are two major driving factors propelling the market growth in the region. Asia Pacific AI-powered CT diagnostic imaging market accounts for over 23% of the business share in 2023 and is likely to grow at a substantial rate over the forecast timeline. The healthcare sector across the region is showcasing a robust technological transformation. Increasing disposable income in economies such as India, China, and Japan are likely to offer lucrative business opportunities for new market entrants in the forthcoming years.
AI-powered Computed Tomography Diagnostic Imaging Market – By Companies.
Agfa Healthcare
Ada Health GmbH
Arterys
Bay Labs, Inc. (Caption Health Inc.)
Babylon
BenevolentAI
Butterfly Network, Inc.
EchoNous, Inc.
Enlitic, Inc.
Gauss Surgical
GE Healthcare
IBM Corporation
Lunit Inc.
Microsoft Corporation
NVIDIA Corporation
Philips Healthcare
OrCam
Qure.ai
Siemens Healthineers AG
Zebra Medical Vision
The AI-powered Computed Tomography Diagnostic Imaging Market is highly fragmented and extremely competitive with key players involved in R&D and constant technological innovation done by the vendors.
Recent Industry Developments:
In June 2021, Perimeter Medical Imaging AI announced the successful technology transfer with Minnetronix Medical for the development of optical coherence tomography (OCT) imaging systems
Chapter 1. AI-powered Computed Tomography Diagnostic Imaging Market – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. AI-powered Computed Tomography Diagnostic Imaging Market – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 - 2030
2.3.2. Impact on Supply – Demand
Chapter 3. AI-powered Computed Tomography Diagnostic Imaging Market – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. AI-powered Computed Tomography Diagnostic Imaging Market - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. AI-powered Computed Tomography Diagnostic Imaging Market- Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. AI-powered Computed Tomography Diagnostic Imaging Market – Type
6.1 Low Slice
6.2 Medium Slice
6.3 High Slice
Chapter 7. AI-powered Computed Tomography Diagnostic Imaging Market – Solution
7.1 Software Tools/Platforms
7.2 Services
7.3 Integration
7.4 Deployment
Chapter 8. AI-powered Computed Tomography Diagnostic Imaging Market – Technology
8.1 Deep Learning
8.2 Computer Vision
8.3 Others
Chapter 9. AI-powered Computed Tomography Diagnostic Imaging Market – Application
9.1 Oncology
9.2 Neurology
9.3 Cardiovascular
9.4 Musculoskeletal
9.5 Others
Chapter 10. AI-powered Computed Tomography Diagnostic Imaging Market – By End User.
10.1 Hospitals
10.2 Clinics
10.3 Diagnostic Centres
10.4 R&D Centres
10.5 Others
Chapter 11. AI-powered Computed Tomography Diagnostic Imaging Market – By Region
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 South America
11.5 Middle-East and Africa
Chapter 12. AI-powered Computed Tomography Diagnostic Imaging Market – By Companies
12.1 Agfa Healthcare
12.2 Ada Health GmbH
12.3 Arterys
12.4 Bay Labs, Inc. (Caption Health Inc.)
12.5 Babylon
12.6 BenevolentAI
12.7 Butterfly Network, Inc.
12.8 EchoNous, Inc.
12.9 Enlitic, Inc.
12.10 Gauss Surgical
12.11 GE Healthcare
12.12 IBM Corporation
12.13 Lunit Inc.
12.14 Microsoft Corporation
12.15 NVIDIA Corporation
12.16 Philips Healthcare
12.17 OrCam
12.18 Qure.ai
12.19 Siemens Healthineers AG
12.20 Zebra Medical Vision
2500
4250
5250
6900
Frequently Asked Questions
The rapid rise in growing health concerns in the geriatric population along with the penetration of advanced technologies is propelling the growth of the AI-powered Computed Tomography Diagnostic Imaging Market worldwide.
Agfa Healthcare, Bay Labs, Inc. (Caption Health Inc.), Babylon, Ada Health GmbH, Arterys, Butterfly Network, Inc., EchoNous, Inc., BenevolentAI, and Enlitic, Inc. are the key players involved in the AI-powered Computed Tomography Diagnostic Imaging Market in 2022.
The rising COVID-19 cases across the globe and emerging AI technologies have positively impacted the global market and have boosted the demand for AI-powered Computed Tomography Diagnostic Imaging by providing remote access to images and reports augmenting the global market size.
The North American market region dominates the AI-powered Computed Tomography diagnostic imaging market in 2022 owing to the increasing capital investments opening up new doors of opportunities in the region.
The Global AI-powered Computed Tomography Diagnostic Imaging Market is anticipated to grow at a CAGR of around 25.4% during the forecast period, 2023-2030.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.